Brooklyn, NY, United States of America

Rony Krell

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Optum, Inc., Unitedhealth Group Incorporated. Active years: 2025-2026.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 4.2

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Rony Krell: Innovator in Multi-Armed Bandit Models

Introduction

Rony Krell is a notable inventor based in Brooklyn, NY (US). He has made significant contributions to the field of machine learning, particularly in the development of systems and methods for training multi-armed bandit models. His innovative approach has the potential to enhance treatment recommendations in clinical settings.

Latest Patents

Rony Krell holds a patent for "Systems and methods for training multi-armed bandit models." This patent describes a method for determining a treatment recommendation using a multi-armed bandit (MAB) model. The process involves receiving first patient information and determining the treatment recommendation based on this information. The MAB model is trained using a combination of second patient information and clinical treatment recommendations, ultimately providing a tailored treatment suggestion.

Career Highlights

Rony Krell is currently employed at UnitedHealth Group Incorporated, where he applies his expertise in machine learning to improve healthcare outcomes. His work focuses on integrating advanced algorithms into clinical decision-making processes, which can lead to more effective patient care.

Collaborations

Rony collaborates with talented professionals such as Mohsen Afrasiabi and Tanzeem Choudhury. Together, they work on innovative projects that aim to push the boundaries of healthcare technology.

Conclusion

Rony Krell's contributions to the field of multi-armed bandit models exemplify the intersection of technology and healthcare. His innovative patent and collaborative efforts highlight the importance of advancements in clinical decision-making.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…